{"component": "definition", "props": {"groups": [{"snippet_links": [{"key": "program-invention", "type": "definition", "offset": [28, 45]}], "samples": [{"hash": "b8BT2sZJ2e3", "uri": "/contracts/b8BT2sZJ2e3#program-patent", "label": "Collaboration Agreement (Leap Therapeutics, Inc.)", "score": 35.611907959, "published": true}, {"hash": "lsypqMsFK4s", "uri": "/contracts/lsypqMsFK4s#program-patent", "label": "Collaboration Agreement (Leap Therapeutics, Inc.)", "score": 34.3661880493, "published": true}, {"hash": "dOZzLDIUhua", "uri": "/contracts/dOZzLDIUhua#program-patent", "label": "Collaboration Agreement (Adagio Therapeutics, Inc.)", "score": 32.5373039246, "published": true}], "snippet": "means any Patent Covering a Program Invention.", "size": 39, "hash": "c0dc91aad117079713ee727e72d9e147", "id": 1}, {"snippet_links": [{"key": "inventions-or-discoveries", "type": "clause", "offset": [24, 49]}, {"key": "the-program", "type": "clause", "offset": [53, 64]}], "samples": [{"hash": "kQH5PI8O1rK", "uri": "/contracts/kQH5PI8O1rK#program-patent", "label": "License and Research Agreement (Rigel Pharmaceuticals Inc)", "score": 21.0, "published": true}, {"hash": "7Jnfsriks76", "uri": "/contracts/7Jnfsriks76#program-patent", "label": "License and Research Agreement (Rigel Pharmaceuticals Inc)", "score": 21.0, "published": true}, {"hash": "5jm82sQr2vW", "uri": "/contracts/5jm82sQr2vW#program-patent", "label": "License and Research Agreement (Rigel Pharmaceuticals Inc)", "score": 21.0, "published": true}], "snippet": "means a Patent claiming inventions or discoveries in the Program Know-How.", "size": 9, "hash": "a2e419d1e3e72c9ecddc608ea5795106", "id": 2}, {"snippet_links": [{"key": "the-program", "type": "clause", "offset": [60, 71]}], "samples": [{"hash": "ltB65g1GyMW", "uri": "/contracts/ltB65g1GyMW#program-patent", "label": "Marketing and Supply Agreement (Arena Pharmaceuticals Inc)", "score": 25.1670093536, "published": true}, {"hash": "8plxskSEnlj", "uri": "/contracts/8plxskSEnlj#program-patent", "label": "Marketing and Supply Agreement (Arena Pharmaceuticals Inc)", "score": 23.6036968231, "published": true}, {"hash": "fprzFGrOWX3", "uri": "/contracts/fprzFGrOWX3#program-patent", "label": "Marketing and Supply Agreement (Arena Pharmaceuticals Inc)", "score": 21.8542098999, "published": true}], "snippet": "means any Patent that claims or covers any invention within the Program Know-How.", "size": 7, "hash": "6d8d8b96b4fbfc0f53d9bc59dc489115", "id": 3}, {"snippet_links": [{"key": "patent-application", "type": "clause", "offset": [18, 36]}, {"key": "program-improvement", "type": "clause", "offset": [63, 82]}], "samples": [{"hash": "b6xu7disJBB", "uri": "/contracts/b6xu7disJBB#program-patent", "label": "Licensing, Development, Manufacturing and Marketing Agreement", "score": 27.0396995544, "published": true}, {"hash": "5mvcl2kMKtV", "uri": "/contracts/5mvcl2kMKtV#program-patent", "label": "License and Collaboration Agreement (Amicus Therapeutics Inc)", "score": 23.8473644257, "published": true}, {"hash": "33OVxpyZw40", "uri": "/contracts/33OVxpyZw40#program-patent", "label": "License and Collaboration Agreement (Amicus Therapeutics Inc)", "score": 22.1690616608, "published": true}], "snippet": "means a Patent or Patent application disclosing and claiming a Program Improvement.", "size": 4, "hash": "f508f2aee8c473e71bcfb8fcc3fd6aee", "id": 4}, {"snippet_links": [{"key": "patent-rights", "type": "clause", "offset": [6, 19]}, {"key": "by-rbnc", "type": "clause", "offset": [31, 38]}, {"key": "after-the-effective-date", "type": "clause", "offset": [73, 97]}], "samples": [{"hash": "8Ut7xEuLuIM", "uri": "/contracts/8Ut7xEuLuIM#program-patent", "label": "Exclusive License Agreement (Neumora Therapeutics, Inc.)", "score": 34.6454467773, "published": true}, {"hash": "7uyCthTPTXf", "uri": "/contracts/7uyCthTPTXf#program-patent", "label": "Exclusive License Agreement (Neumora Therapeutics, Inc.)", "score": 34.6454467773, "published": true}, {"hash": "ajNxmeeTu4G", "uri": "/contracts/ajNxmeeTu4G#program-patent", "label": "Exclusive License Agreement (Neumora Therapeutics, Inc.)", "score": 33.120464325, "published": true}], "snippet": "means Patent Rights Controlled by RBNC or its Affiliates or Sublicensees after the Effective Date that Cover [***].", "size": 4, "hash": "e4bcebe34c34668fcf04979dc1396eae", "id": 5}, {"snippet_links": [{"key": "subject-of", "type": "clause", "offset": [22, 32]}, {"key": "to-practice", "type": "clause", "offset": [90, 101]}, {"key": "affiliate-of", "type": "definition", "offset": [125, 137]}, {"key": "by-a-third-party", "type": "clause", "offset": [149, 165]}, {"key": "jointly-invented", "type": "definition", "offset": [240, 256]}, {"key": "in-the-course-of", "type": "definition", "offset": [266, 282]}, {"key": "the-research", "type": "clause", "offset": [283, 295]}, {"key": "in-connection-with", "type": "clause", "offset": [322, 340]}, {"key": "collaboration-compounds", "type": "clause", "offset": [387, 410]}, {"key": "following-the", "type": "definition", "offset": [441, 454]}, {"key": "research-period", "type": "definition", "offset": [455, 470]}, {"key": "method-of-use", "type": "clause", "offset": [538, 551]}, {"key": "method-of-manufacture", "type": "clause", "offset": [555, 576]}, {"key": "appendix-ii", "type": "definition", "offset": [676, 687]}], "samples": [{"hash": "acw7rO4R8Ok", "uri": "/contracts/acw7rO4R8Ok#program-patent", "label": "Research and Development (Addex Therapeutics Ltd.)", "score": 30.9575634003, "published": true}, {"hash": "emLwDPlNsiO", "uri": "/contracts/emLwDPlNsiO#program-patent", "label": "Research and Development (Addex Therapeutics Ltd.)", "score": 30.9028072357, "published": true}, {"hash": "3nD51FUt7I0", "uri": "/contracts/3nD51FUt7I0#program-patent", "label": "Research and Development (Addex Therapeutics Ltd.)", "score": 30.7275829315, "published": true}], "snippet": "means any Patent, the subject of which is an invention (i) that was conceived and reduced to practice by OMP or ADDEX (or an Affiliate of either) or by a Third Party under a contract with OMP or ADDEX (or an Affiliates of either) including Jointly Invented Patents, in the course of the Research, or their respective work in connection with the discovery identification and synthesis of Collaboration Compounds during the [***] month period following the Research Period and (ii) that comprises a Collaboration Compound or a formulation, method of use or method of manufacture thereof. Regardless of the above, Program Patent specifically includes the ADDEX Patents listed in Appendix II and worldwide equivalents thereof.", "size": 3, "hash": "bafd239f58917ec997d8aa40b2279f46", "id": 6}, {"snippet_links": [{"key": "patent-rights", "type": "clause", "offset": [6, 19]}, {"key": "licensed-patents", "type": "definition", "offset": [35, 51]}, {"key": "as-of-the-effective-date", "type": "clause", "offset": [113, 137]}], "samples": [{"hash": "2JLP4lIMeiK", "uri": "/contracts/2JLP4lIMeiK#program-patent", "label": "Exclusive License Agreement (Vigil Neuroscience, Inc.)", "score": 32.882270813, "published": true}, {"hash": "aaH3n6BAqVl", "uri": "/contracts/aaH3n6BAqVl#program-patent", "label": "Exclusive License Agreement (Vigil Neuroscience, Inc.)", "score": 32.7672843933, "published": true}], "snippet": "means Patent Rights (excluding the Licensed Patents) owned or licensed by \u2587\u2587\u2587\u2587\u2587, its Affiliates or Sublicensees, as of the Effective Date or thereafter, that Cover [***].", "size": 2, "hash": "5ffce7457b1f39bd2b13de1e815501a5", "id": 7}, {"snippet_links": [{"key": "all-patents", "type": "clause", "offset": [10, 21]}, {"key": "country-of-origin", "type": "clause", "offset": [37, 54]}, {"key": "directly-related-to", "type": "definition", "offset": [88, 107]}, {"key": "the-purpose-of-this-agreement", "type": "clause", "offset": [108, 137]}, {"key": "to-practice", "type": "clause", "offset": [180, 191]}, {"key": "work-performed", "type": "definition", "offset": [213, 227]}, {"key": "pursuant-to-this-agreement", "type": "clause", "offset": [228, 254]}, {"key": "by-employees", "type": "clause", "offset": [255, 267]}, {"key": "of-the-parties", "type": "clause", "offset": [278, 292]}], "samples": [{"hash": "8RBOlHWhxU2", "uri": "/contracts/8RBOlHWhxU2#program-patent", "label": "Teaming Agreement (Quantum Fuel Systems Technologies Worldwide Inc)", "score": 18.0, "published": true}], "snippet": "refers to all patents, regardless of country of origin or issue that cover an invention directly related to the purpose of this Agreement and which were conceived or first reduced to practice in the course of the work performed pursuant to this Agreement by employees or agents of the Parties.", "size": 2, "hash": "8c00eb3bcb139bf09fb4919f811113f6", "id": 8}, {"snippet_links": [], "samples": [{"hash": "c5blvfjy66l", "uri": "/contracts/c5blvfjy66l#program-patent", "label": "Collaboration and License Agreement (Denali Therapeutics Inc.)", "score": 31.8446273804, "published": true}], "snippet": "means any [***].", "size": 2, "hash": "a824db1dc552d3f1d372fcd9fd10cf2b", "id": 9}, {"snippet_links": [], "samples": [{"hash": "8MRd8mvYICJ", "uri": "/contracts/8MRd8mvYICJ#program-patent", "label": "Collaboration and License Agreement (Arrowhead Pharmaceuticals, Inc.)", "score": 32.5920600891, "published": true}], "snippet": "has the meaning set forth in Section 9.1(b)(i).", "size": 1, "hash": "440cc9172b7f1e180475b18ccabd338f", "id": 10}], "next_curs": "ClsSVWoVc35sYXdpbnNpZGVyY29udHJhY3RzcjcLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIXcHJvZ3JhbS1wYXRlbnQjMDAwMDAwMGEMogECZW4YACAA", "definition": {"title": "Program Patent", "snippet": "means any Patent Covering a Program Invention.", "size": 84, "id": "program-patent", "examples": ["Neither Party may settle any patent infringement litigation under this Section 8.4 in a manner that admits the invalidity or unenforceability of the other Party\u2019s Patents or a <strong>Program Patent</strong> or imposes on the other Party restrictions or obligations or other liabilities, without the written consent of such other Party, which consent shall not be unreasonably withheld, conditioned, or delayed.", "The Prosecuting Party shall notify the other Party of its intention to suspend or cease any Prosecution and Maintenance of any <strong>Program Patent</strong> at least [* * *] prior to any filing or payment due date, or any other due date that requires action, in connection with such <strong>Program Patent</strong>.", "In such event, the Prosecuting Party shall permit the other Party, at its discretion and at its sole expense, to continue Prosecution and Maintenance of such <strong>Program Patent</strong>; provided, that in the case where \u2587\u2587\u2587\u2587\u2587 is the Prosecuting party and Avidity desires to continue Prosecution and Maintenance of such <strong>Program Patent</strong>, Avidity shall not continue such prosecution and maintenance if \u2587\u2587\u2587\u2587\u2587 reasonably objects to the prosecution or maintenance by Avidity of such <strong>Program Patent</strong>.", "The Parties shall cooperate in determining which Patent claiming or covering a Compound or Product should be extended, and thereafter the Parties shall cooperate in obtaining patent term restorations, supplemental protection certificates or their equivalents, and other forms of patent term extensions for a given Compound or Product with respect to any applicable Avidity Patent, Lilly Patent, or <strong>Program Patent</strong> in any country or region where applicable."], "related": [["program-patent-rights", "Program Patent Rights", "<strong>Program Patent</strong> Rights"], ["collaboration-patent-rights", "Collaboration Patent Rights", "Collaboration Patent Rights"], ["joint-patent-rights", "Joint Patent Rights", "Joint Patent Rights"], ["patent-right", "Patent Right", "Patent Right"], ["licensed-patent-rights", "Licensed Patent Rights", "Licensed Patent Rights"]], "related_snippets": [], "updated": "2026-02-03T04:20:59+00:00"}, "json": true, "cursor": ""}}